Literature DB >> 10228829

Helicobacter pylori infection in dyspeptic cirrhotic patients.

A Zullo1, V Rinaldi, P Meddi, S Folino, V Lauria, F Diana, S Winn, A F Attili.   

Abstract

BACKGROUND/AIMS: To date, few studies have focused on the role of Helicobacter pylori (H. pylori) in cirrhotic patients with gastroduodenal disease and reported results are conflicting. The aim of this study was to assess the H. pylori infection rate in dyspeptic cirrhotic patients with or without gastroduodenal lesions at endoscopy.
METHODOLOGY: In a prospective study, 226 consecutive dyspeptic cirrhotic patients were enrolled in the study upon assessment of H. pylori infection. Two-hundred dyspeptic non-cirrhotic patients were also included as controls. The presence of H. pylori was detected by rapid urease test and histology (Giemsa staining) in 3 biopsy specimens from the antrum and 3 from the gastric body.
RESULTS: H. pylori infection was found in 135 (59.7%) cirrhotics and in 121 (60.5%) controls (p = NS). The prevalence of gastric ulcer was higher in cirrhotics than in controls (16% vs. 2.5%, p = 0.0001), while the prevalence of duodenal ulcer was similar (11% vs. 12%, respectively). The H. pylori infection rate was similar between cirrhotics and controls, both with gastric (83% vs. 80%) and with duodenal (88% vs. 96%) ulcers. Moreover, in our study, a H. pylori-related peptic lesion was the cause of previous gastroduodenal bleeding in 6 of 50 (12%) cirrhotic patients.
CONCLUSIONS: Our results indicated that H. pylori infection is implicated in the pathogenesis of peptic ulcer in cirrhotic patients, similar to findings in non-cirrhotic patients.

Entities:  

Mesh:

Year:  1999        PMID: 10228829

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Gastric epithelial cell proliferation in patients with liver cirrhosis.

Authors:  A Zullo; A Romiti; V Rinaldi; A Vecchione; C Hassan; S Winn; S Tomao; A F Attili
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

3.  Helicobacter pylori seroprevalence in patients with autoimmune hepatitis.

Authors:  Marilena Durazzo; Rinaldo Pellicano; Alberto Premoli; Mara Berrutti; Nicola Leone; Antonio Ponzetto; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

Review 4.  Upper Gastrointestinal Cancer and Liver Cirrhosis.

Authors:  Kuo-Shyang Jeng; Chiung-Fang Chang; I-Shyan Sheen; Chi-Juei Jeng; Chih-Hsuan Wang
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

5.  Usefulness of the immunological rapid urease test for detection of Helicobacter pylori in patients who are reluctant to undergo endoscopic biopsies.

Authors:  Hajime Isomoto; Kaoru Kawazoe; Kenichiro Inoue; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.199

Review 6.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

7.  High prevalence of asymptomatic peptic ulcers diagnosed during screening endoscopy in patients with cirrhosis.

Authors:  Theodoros Voulgaris; Dimitrios Karagiannakis; Spyridon Siakavellas; Despina Kalogera; Theodoros Angelopoulos; Elissavet Chloupi; George Karamanolis; George Papatheodoridis; John Vlachogiannakos
Journal:  Ann Gastroenterol       Date:  2019-07-06

8.  Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis.

Authors:  Dong Joon Kim; Hak Yang Kim; Sung Jung Kim; Tae Ho Hahn; Myoung Kuk Jang; Gwang Ho Baik; Jin Bong Kim; Sang Hoon Park; Myung-Seok Lee; Choong Kee Park
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.